ABC News’ speaks with law professor Anya Prince on how 23andMe’s recent layoffs and shuttering of its drug development arm ...

Nearly 7 million of 23andMe's customers were exposed in a recent data leak. Now they -- and potentially, you -- could be in line for a major payout.

The future of 23andMe, a genetic testing company, is uncertain due to financial challenges and recent workforce reductions.

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

SUNNYVALE, Calif. and SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive ...

Me, the popular at-home genetic testing company, has helped millions of people uncover their family roots and health risks through DNA analysis. Experts fear as the company faces financial issues they ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

In the year since its devastating hack, 23andMe has lost all of its value and most of its governing board — and somehow, ...

Me Holding Co. (NASDAQ: ME) shares barely cleared breakeven Wednesday. The company, a leading human genetics and preventive health company, and Mirador Therapeutics, a next-generation precision ...

( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...